(Q46832308)

25 December 2017

title

Overtreatment of men with low-risk prostate cancer and significant comorbidity. (English)

1 reference

25 December 2017

1 reference

1 reference

Timothy J Daskivich

1

1 reference

25 December 2017

Karim Chamie

2

1 reference

25 December 2017

Lorna Kwan

3

1 reference

25 December 2017

Jessica Labo

4

1 reference

25 December 2017

Roland Palvolgyi

5

1 reference

25 December 2017

Atreya Dash

6

1 reference

25 December 2017

Sheldon Greenfield

7

1 reference

25 December 2017

Mark S Litwin

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

29 November 2010

1 reference

25 December 2017

published in

Cancer

1 reference

25 December 2017

volume

117

1 reference

25 December 2017

issue

10

1 reference

25 December 2017

page(s)

2058-2066

1 reference

25 December 2017

Guideline for the management of clinically localized prostate cancer: 2007 update.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Time course and predictors of symptoms after primary prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Outcomes of localized prostate cancer following conservative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

How to measure comorbidity. a critical review of available methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

NCCN clinical practice guidelines in oncology: prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

7 January 2021

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

7 January 2021

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

7 January 2021

Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

7 January 2021

The impact of co-morbidity on life expectancy among men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25751

7 January 2021

Identifiers

DOI

10.1002/CNCR.25751

1 reference

25 December 2017

1 reference

25 December 2017